NM_015459.5:c.557T>C
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 4P and 4B. PP3_StrongBS2
The NM_015459.5(ATL3):c.557T>C(p.Leu186Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000376 in 1,595,236 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 14/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L186R) has been classified as Uncertain significance.
Frequency
Consequence
NM_015459.5 missense
Scores
Clinical Significance
Conservation
Publications
- neuropathy, hereditary sensory, type 1FInheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
- hereditary sensory and autonomic neuropathy type 1Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_015459.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATL3 | NM_015459.5 | MANE Select | c.557T>C | p.Leu186Pro | missense | Exon 5 of 13 | NP_056274.3 | ||
| ATL3 | NM_001290048.2 | c.503T>C | p.Leu168Pro | missense | Exon 5 of 13 | NP_001276977.1 | |||
| ATL3 | NM_001440717.1 | c.557T>C | p.Leu186Pro | missense | Exon 5 of 12 | NP_001427646.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATL3 | ENST00000398868.8 | TSL:1 MANE Select | c.557T>C | p.Leu186Pro | missense | Exon 5 of 13 | ENSP00000381844.3 | ||
| ATL3 | ENST00000538786.1 | TSL:2 | c.503T>C | p.Leu168Pro | missense | Exon 5 of 13 | ENSP00000437593.1 | ||
| ENSG00000256789 | ENST00000540307.2 | TSL:3 | n.553+1193A>G | intron | N/A |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152232Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000863 AC: 2AN: 231636 AF XY: 0.0000159 show subpopulations
GnomAD4 exome AF: 0.00000346 AC: 5AN: 1443004Hom.: 0 Cov.: 30 AF XY: 0.00000418 AC XY: 3AN XY: 717536 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152232Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74376 show subpopulations
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.557T>C (p.L186P) alteration is located in exon 5 (coding exon 5) of the ATL3 gene. This alteration results from a T to C substitution at nucleotide position 557, causing the leucine (L) at amino acid position 186 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at